Back to top
more

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Janus Global Life Sciences D Shs: (MF: JNGLX)

(MF) As of Jul 1, 2015 06:05 PM ET

 Add to portfolio

$62.64 USD

+0.39 (0.63%)

Zacks MF Rank : 1 - Strong Buy [?] 1        

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Latest Performance as of May 31, 2015

Total Return %* Percentile Rank Objective
YTD 18.64 18
3 months 7.18 23
6 months 20.94 18
1 Year 48.08 19
3 Year 40.97 12
5 Year 31.09 20
10 Year 15.70 28

* Annual for three years and beyond.

Zacks Premium Research for JNGLX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Strong Buy 1
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 28.61
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 5/31/2015 1,712.31
%Turnover 5/31/2015 44.00

Risk

3 Year 5 Year 10 Year
Beta 0.73 0.75 0.76
Alpha 24.41 17.38 8.71
R Squared 0.25 0.49 0.58
Std. Dev. 12.32 13.08 15.00
Sharpe 3.40 2.45 1.00

Sector / Country Weightings

As of 5/31/2015 % of Portfolio
Health 57.51
Other 11.37
Industrial Cyclical 10.91
Services 8.71
Finance 6.04
Retail Trade 2.77
Technology 1.43
Non-Durable 1.26

Portfolio Holdings

Top Equity Holdings
(As of 3/31/2015)
% of Portfolio Value (Mil$)
JOHNSON & JOHNSON 2.98 129.55
AMGEN INC 2.83 122.65
BIOGEN IDEC INC 2.71 117.61
ACTAVIS PLC 2.42 104.87
VALEANT PHARMACEUTICALS 2.37 102.92
ABBVIE INC 2.22 96.53
CELGENE CORP 2.15 93.34
ROCHE HOLDING AG GENUSSS 2.15 93.31
BOSTON SCIENTIFIC CORP 1.96 85.00

Stock Holding % of Net Assets

As Of 3/31/2015
Total Issues 93
Avg. P/E 29.21
Avg. P/Book 5.74
Avg. EPS Growth 12.4
Avg. Market Value (Mil $) 54,161

Allocation

% of Portfolio
Large Growth 25.02
Large Value 0.00
Small Growth 29.19
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 17.08
Foreign Bond 0.00
High Yield Bond 0.00